LGND - Ligand Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LGND is currently covered by 6 analysts with an average price target of $177.47. This is a potential upside of $18.39 (11.56%) from yesterday's end of day stock price of $159.08.

Ligand Pharmaceuticals's activity chart (see below) currently has 127 price targets and 106 ratings on display. The stock rating distribution of LGND is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 93.82% with an average time for these price targets to be met of 351.33 days.

Highest price target for LGND is $160, Lowest price target is $135, average price target is $145.

Most recent stock forecast was given by ROBERT WASSERMAN from BENCHMARK on 23-Dec-2024. First documented stock forecast 12-Feb-2014.

Currently out of the existing stock ratings of LGND, 28 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$135

$-24.08 (-15.14%)

$135

8 months 1 days ago
(23-Dec-2024)

9/9 (100%)

$21.2 (18.63%)

215

Buy

$160

$0.92 (0.58%)

$150

8 months 8 days ago
(16-Dec-2024)

14/15 (93.33%)

$37.66 (30.78%)

529

Buy

$157

8 months 13 days ago
(11-Dec-2024)

33/40 (82.5%)

$35.75 (29.48%)

466

Buy

$143

$-16.08 (-10.11%)

$140

8 months 13 days ago
(11-Dec-2024)

5/5 (100%)

$22.64 (18.81%)

305

Buy

$147

$-12.08 (-7.59%)

$135

9 months 16 days ago
(08-Nov-2024)

2/2 (100%)

$25.75 (21.24%)

280

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LGND (Ligand Pharmaceuticals) average time for price targets to be met?

On average it took 351.33 days on average for the stock forecasts to be realized with a an average price target met ratio 93.82

Which analyst has the current highest performing score on LGND (Ligand Pharmaceuticals) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the most public recommendations on LGND (Ligand Pharmaceuticals)?

Joseph Pantginis has 32 price targets and 24 ratings on LGND

Which analyst is the currently most bullish on LGND (Ligand Pharmaceuticals)?

Jeff Johnson with highest potential upside - $4.82

Which analyst is the currently most reserved on LGND (Ligand Pharmaceuticals)?

Esther Rajavelu with lowest potential downside - -$93.58

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?